Atogepant shows efficacy for prevention of migraine
Atogepant, an oral drug approved in the US for the prevention of episodic migraine treatment appears to also be effective for the prevention of chronic migraine. The findings… read more.
Atogepant, an oral drug approved in the US for the prevention of episodic migraine treatment appears to also be effective for the prevention of chronic migraine. The findings… read more.
Bariatric surgery treats advanced non-alcoholic fatty liver disease (NASH) significantly more effectively than drug or lifestyle intervention, researchers reported on April 20, 2023 in The Lancet. Professor Francesco… read more.
Exenatide, an injectable treatment for type 2 diabetes, has shown efficacy for the treatment of ‘blinding’ headaches known as idiopathic intercranial hypertension (IIH). Researchers from a phase 2… read more.
Among persons diagnosed with type 2 diabetes, consumption of tea, coffee or water rather than sugary drinks has been linked to lower rates of early death due to… read more.
Patients who chose active monitoring of their localized prostate cancer have achieved the same high survival rates as those who chose radiotherapy or surgery. Researchers reported these findings… read more.
Among patients over 60 with treatment-resistant depression, adding the antipsychotic drug aripiprazole (Abilify) to their treatment appears to be a more effective strategy than switching antidepressants. Researchers reported… read more.
People with hearing loss who do not use hearing aids appear to be at a higher risk of developing dementia than people with hearing loss who use hearing… read more.
Researchers report that patients who knowingly took a “sugar pill” placebo along with daily methadone treatment achieved significantly higher 90-day adherence to treatment for opioid abuse disorder than… read more.
Researchers from the NEOSTAR Phase II trial reported that the addition of ipilimumab to a neoadjuvant (pre-surgical) combination of nivolumab plus platinum-based chemotherapy resulted in a major pathologic… read more.
An artificial pancreas improves blood sugar control in children ages 2 to 6 with type 1 diabetes, researchers reported on March 16, 2023 the NEJM/New England Journal of… read more.
The hunger hormone ghrelin appears to increase pumping capacity in patients with heart failure, researchers reported on March 14, 2023 in European Heart Journal. “Heart failure is the… read more.
One dose of the antibiotic azithromycin appears to reduce significantly the risk of postpartum sepsis and death among women who have a vaginal delivery. The findings were reported… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.